We are live on ! Find out more
BPCE

Bank Pictet & Cie (Europe) Portfolio holdings

AUM $5.12B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+3.38%
1 Year Est. Return
+27.39%
3 Year Est. Return
+99.4%
5 Year Est. Return
+123.97%
10 Year Est. Return
+508.14%
AUM
$2.49B
AUM Growth
+$450M
Cap. Flow
+$403M
Cap. Flow %
16.19%
Top 10 Hldgs %
43.41%
Holding
209
New
33
Increased
83
Reduced
31
Closed
36

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$139M
2
C icon
Citigroup
C
+$29M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$27.5M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$16.4M
5
MSFT icon
Microsoft
MSFT
+$15.9M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$24.4M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$11.5M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$7.94M
4
GLD icon
SPDR Gold Trust
GLD
+$5.03M
5
BABA icon
Alibaba
BABA
+$5M

Sector Composition

Rank Sector Weight
1 Healthcare 23.1%
2 Technology 17.53%
3 Consumer Discretionary 14.48%
4 Communication Services 12.6%
5 Financials 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABMD
126
DELISTED
Abiomed Inc
ABMD
$496K 0.02%
+1,556
New +$498K
AKAM icon
127
Akamai
AKAM
$18.2B
$489K 0.02%
4,796
+2,219
+86% +$229K
NFLX icon
128
Netflix
NFLX
$321B
$459K 0.02%
8,800
-5,060
-37% -$268K
RSP icon
129
Invesco S&P 500 Equal Weight ETF
RSP
$100B
$421K 0.02%
2,971
+550
+23% +$74.2K
IRTC icon
130
iRhythm Holdings
IRTC
$4.1B
$411K 0.02%
+2,963
New +$531K
TNDM icon
131
Tandem Diabetes Care
TNDM
$1.62B
$406K 0.02%
+4,600
New +$428K
VCSH icon
132
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
$399K 0.02%
4,832
– –
AMGN icon
133
Amgen
AMGN
$226B
$390K 0.02%
1,568
+480
+44% +$115K
TXG icon
134
10x Genomics
TXG
$7.72B
$379K 0.02%
+2,092
New +$361K
AGG icon
135
iShares Core US Aggregate Bond ETF
AGG
$138B
$377K 0.02%
3,312
– –
LLY icon
136
Eli Lilly
LLY
$1.09T
$374K 0.02%
2,000
– –
PACB icon
137
Pacific Biosciences
PACB
$354M
$374K 0.02%
+11,232
New +$393K
ROST icon
138
Ross Stores
ROST
$78.6B
$374K 0.02%
3,119
-900
-22% -$107K
LMT icon
139
Lockheed Martin
LMT
$139B
$370K 0.01%
+1,000
New +$343K
MRNA icon
140
Moderna
MRNA
$25.9B
$369K 0.01%
+2,820
New +$409K
UBS icon
141
UBS Group
UBS
$176B
$365K 0.01%
23,470
-16,600
-41% -$255K
TT icon
142
Trane Technologies
TT
$106B
$363K 0.01%
2,193
+461
+27% +$71.4K
ABBV icon
143
AbbVie
ABBV
$446B
$350K 0.01%
+3,230
New +$345K
PRGO icon
144
Perrigo
PRGO
$1.78B
$350K 0.01%
8,650
– –
XYL icon
145
Xylem
XYL
$28.1B
$349K 0.01%
3,316
+784
+31% +$79.5K
TDOC icon
146
Teladoc Health
TDOC
$1.27B
$347K 0.01%
+1,909
New +$443K
PODD icon
147
Insulet
PODD
$9.95B
$344K 0.01%
+1,319
New +$353K
APLS
148
DELISTED
Apellis Pharmaceuticals
APLS
$338K 0.01%
+7,881
New +$373K
DBX icon
149
Dropbox
DBX
$7.37B
$321K 0.01%
+12,051
New +$290K
QDEL icon
150
QuidelOrtho
QDEL
$1.01B
$315K 0.01%
+2,462
New +$455K
4 5
6
7 8

Similar funds

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
MIM
Merewether Investment Management Dallas, Texas $5.16B AUM 86.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
NL
NEPC LLC Boston, Massachusetts $5.02B AUM 7.87% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s Q1 2021 Portfolio in Review

As of Q1 2021, Bank Pictet & Cie (Europe) held 209 positions worth $2.49B, up 22% from $2.04B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Bank Pictet & Cie (Europe) deployed $403M of net new capital in Q1 2021, opening 33 new positions and adding to 83 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 109,390 shares worth $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $24.4M trimmed.

  • Bank Pictet & Cie (Europe)'s largest Q1 2021 buy was State Street SPDR S&P Biotech ETF: 109,390 shares worth $14.8M.
  • Bank Pictet & Cie (Europe) added most to Invesco QQQ Trust in Q1 2021, an estimated $139M increase.
  • Bank Pictet & Cie (Europe)'s biggest Q1 2021 reduction was Bristol-Myers Squibb, cutting an estimated $24.4M.
  • Bank Pictet & Cie (Europe) fully exited NIO in Q1 2021, selling an estimated $1.08M.
  • Bank Pictet & Cie (Europe)'s ten largest holdings make up 43% of its $2.49B portfolio in Q1 2021.
  • Bank Pictet & Cie (Europe) opened 33 new positions and closed 36 in Q1 2021.
  • Bank Pictet & Cie (Europe)'s portfolio value rose 22% quarter-over-quarter to $2.49B.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2021, filed 10 May 2021.